BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Eppendorf Centrifuge 5910 Ri is the first centrifuge in the market to receive My Green Lab ACT label.

By emphasizing Accountability, Consistency, and Transparency (ACT) around manufacturing, energy and water use, packaging, and end-of-life, the ACT label ma...

March 01, 2023 | News

Clean Cells launches activities at new biopharmaceutical quality control facility - largest in Europe

Company anticipates strong growth in demand and activity, focusing on new treatments such as cell and gene therapies, and offering new and improved service...

March 01, 2023 | News

Everest Medicines Commences Operations at State-of-the-Art mRNA Vaccine Facility.

Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercializa...

February 28, 2023 | News

Precision Medicine Takes Center Stage: Exploring the Innovative Biopharma Industry in Australia and New Zealand

Australia and New Zealand have always been at the forefront of innovation and research in the biopharma industry. The region's strategic location and stron...

February 24, 2023 | News

Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase

In collaboration with researchers from the University of Shizuoka, Aji Bio-Pharma succeeded in developing a highly functional artificial RNA ligase using t...

February 23, 2023 | News

Biocytogen Launches “Nano 100 Project” to Develop Fully Human Nanobody Therapeutics for Over 100 Targets

Compared to traditional antibodies, nanobodies have smaller molecular weights and improved tissue penetration ability, which make them effective at infiltr...

February 22, 2023 | News

GC Biopharma Receives WHO Pre-Qualification for BARYCELA

WHO prequalification decision has made BARYCELA now eligible for procurement by the United Nations agencies, including the Pan American Health Organization...

February 20, 2023 | News

Dalton Announces Major Expansion in Commercial Sterile Manufacturing Capacity

The capital expansion plan includes a new state-of-the-art, fully automated cGMP sterile filling line with the flexibility to fill vials, syringes, a...

February 17, 2023 | News

GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea

This plant is the largest filling and finish facility based in South Korea, established in 2019. GC Biopharma installed an isolator facilities and app...

February 09, 2023 | News

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...

February 03, 2023 | News

Bionomics Released Quarterly Activities and Cashflow Report

Released its Appendix 4C – Quarterly Cashflow Report. Highlights during the Quarter ended 31 December 2022 (Quarter) and up to the date of this annou...

January 31, 2023 | News

Lecanemab Receives Priority Review Status in Japan

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Chri...

January 30, 2023 | News

Alpha Biopharma Submits New Drug Application for Zorifertinib

Alpha Biopharma, a developer of innovative drugs, announces that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA...

January 30, 2023 | News

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

First Generic of Abraxane in Korea, World 4th Commercial Scale-Up Global tech-transfer expected to US, Japan, and Europe Through this contr...

January 26, 2023 | News

Stay Connected